{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:00:07Z","timestamp":1772121607097,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"United Therapeutics Corporation, a grant from CTSA","award":["(U54-TR001012"],"award-info":[{"award-number":["(U54-TR001012"]}]},{"name":"NIAMS CORT","award":["1P50AR060780"],"award-info":[{"award-number":["1P50AR060780"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","semarthritisrheumatism.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.semarthrit.2016.05.015","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T12:59:20Z","timestamp":1465304360000},"page":"465-472","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Changes in gene expression profiles in patients with pulmonary arterial hypertension associated with scleroderma treated with tadalafil"],"prefix":"10.1016","volume":"46","author":[{"given":"Fei-Ying","family":"Cheong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam C.","family":"Gower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harrison W.","family":"Farber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2016.05.015_bib1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pharmthera.2013.10.002","article-title":"Targeted therapies in pulmonary arterial hypertension","volume":"141","author":"Montani","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1183\/09059180.00006411","article-title":"Looking to the future: a new decade of pulmonary arterial hypertension therapy","volume":"20","author":"McLaughlin","year":"2011","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib3","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","article-title":"Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial","volume":"132","author":"Badesch","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.trsl.2012.01.012","article-title":"Peripheral blood biomarkers in idiopathic pulmonary fibrosis","volume":"159","author":"Vij","year":"2012","journal-title":"Transl Res J Lab Clin Med"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib6","unstructured":"Limited Systemic Sclerosis Patients With Pulmonary Arterial Hypertension Show Biomarkers of Inflammation and Vascular Injury. PubMed\u2014NCBI, n.d. \u3008http:\/\/www-ncbi-nlm-nih-gov.ezproxy.bu.edu\/pubmed\/20808962\u3009 [accessed 09.06.15]."},{"key":"10.1016\/j.semarthrit.2016.05.015_bib7","unstructured":"Interferon and Alternative Activation of Monocyte\/Macrophages in Systemic Sclerosis-associated Pulmonary Arterial Hypertension. PubMed\u2014NCBI, n.d. \u3008http:\/\/www-ncbi-nlm-nih-gov.ezproxy.bu.edu\/pubmed\/21425123\u3009 [accessed 09.06.15]."},{"key":"10.1016\/j.semarthrit.2016.05.015_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/biostatistics\/4.2.249","article-title":"Exploration, normalization, and summaries of high density oligonucleotide array probe level data","volume":"4","author":"Irizarry","year":"2003","journal-title":"Biostat Oxf Engl"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/bioinformatics\/btg405","article-title":"affy\u2014analysis of Affymetrix GeneChip data at the probe level","volume":"20","author":"Gautier","year":"2004","journal-title":"Bioinforma Oxf Engl"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib10","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0306-9877(95)90228-7","article-title":"Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus","volume":"45","author":"Klipper-Aurbach","year":"1995","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib12","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib13","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1093\/bioinformatics\/btm369","article-title":"GSEA-P: a desktop application for gene set enrichment analysis","volume":"23","author":"Subramanian","year":"2007","journal-title":"Bioinforma Oxf Engl"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jdermsci.2009.02.013","article-title":"Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension","volume":"55","author":"Hamaguchi","year":"2009","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib15","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1182\/blood.V84.12.4008.bloodjournal84124008","article-title":"Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes","volume":"84","author":"Trinchieri","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib16","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1164\/rccm.201203-0411OC","article-title":"Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension","volume":"186","author":"De Man","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib17","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1164\/rccm.200509-1361OC","article-title":"Serotonin transporter polymorphisms in familial and idiopathic pulmonary arterial hypertension","volume":"173","author":"Willers","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib18","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.healun.2009.01.016","article-title":"Polymorphism in the angiotensin II type 1 receptor (AGTR1) is associated with age at diagnosis in pulmonary arterial hypertension","volume":"28","author":"Chung","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib19","doi-asserted-by":"crossref","first-page":"552S","DOI":"10.1378\/chest.128.6_suppl.552S","article-title":"Serotonin transporter and receptors in various forms of human pulmonary hypertension","volume":"128","author":"Marcos","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib20","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1164\/rccm.200712-1876OC","article-title":"Hyponatremia predicts right heart failure and poor survival in pulmonary arterial hypertension","volume":"177","author":"Forfia","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib21","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1164\/rccm.201403-0442OC","article-title":"Vascular receptor autoantibodies in pulmonary arterial hypertension associated with systemic sclerosis","volume":"190","author":"Becker","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib22","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1469-0691.2010.03285.x","article-title":"Inflammation, immunological reaction and role of infection in pulmonary hypertension","volume":"17","author":"Pullamsetti","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2014.04.007","article-title":"Inflammation in pulmonary hypertension: what we know and what we could logically and safely target first","author":"Cohen-Kaminsky","year":"2014","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib24","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1172\/JCI60658","article-title":"Molecular pathogenesis of pulmonary arterial hypertension","volume":"122","author":"Rabinovitch","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib25","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1160\/TH07-02-0085","article-title":"Chemokines in vascular remodeling","volume":"97","author":"Schober","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib26","unstructured":"El Chami H, Hassoun PM. Immune and inflammatory mechanis. Prog Cardiovasc Dis. 2012. PubMed\u2013NCBI, n.d. \u3008http:\/\/www-ncbi-nlm-nih-gov.ezproxy.bu.edu\/pubmed\/23009917\u3009 [accessed 27.07.13]."},{"key":"10.1016\/j.semarthrit.2016.05.015_bib27","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1161\/CIRCULATIONAHA.112.110619","article-title":"Impaired natural killer cell phenotype and function in idiopathic and heritable pulmonary arterial hypertension","volume":"126","author":"Ormiston","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/thx.34.2.177","article-title":"Electron microscopy of the plexiform lesion","volume":"34","author":"Smith","year":"1979","journal-title":"Thorax"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1165\/rcmb.2007-0066TR","article-title":"Dysfunctional intracellular trafficking in the pathobiology of pulmonary arterial hypertension","volume":"37","author":"Sehgal","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib30","first-page":"547","article-title":"An electron microscopic study of pulmonary vasculitis induced by monocrotaline","volume":"15","author":"Merkow","year":"1966","journal-title":"Lab Investig"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib31","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1164\/ajrccm\/145.5.1196","article-title":"Primary pulmonary hypertension in association with human immunodeficiency virus infection. A possible viral etiology for some forms of hypertensive pulmonary arteriopathy","volume":"145","author":"Mette","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib32","doi-asserted-by":"crossref","first-page":"H1373","DOI":"10.1152\/ajpheart.00990.2006","article-title":"Aberrant cytoplasmic sequestration of eNOS in endothelial cells after monocrotaline, hypoxia, and senescence: live-cell caveolar and cytoplasmic NO imaging","volume":"292","author":"Mukhopadhyay","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib33","doi-asserted-by":"crossref","first-page":"H1141","DOI":"10.1152\/ajpheart.00767.2010","article-title":"Dependence of Golgi apparatus integrity on nitric oxide in vascular cells: implications in pulmonary arterial hypertension","volume":"300","author":"Lee","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib34","doi-asserted-by":"crossref","first-page":"C1837","DOI":"10.1152\/ajpcell.00405.2006","article-title":"Function of Kv1.5 channels and genetic variations of KCNA5 in patients with idiopathic pulmonary arterial hypertension","volume":"292","author":"Remillard","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib35","doi-asserted-by":"crossref","first-page":"e49758","DOI":"10.1371\/journal.pone.0049758","article-title":"Involvement of Kv1.5 protein in oxidative vascular endothelial cell injury","volume":"7","author":"Chen","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib36","doi-asserted-by":"crossref","first-page":"H570","DOI":"10.1152\/ajpheart.01324.2007","article-title":"Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer","volume":"294","author":"Archer","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib37","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0140-6736(05)78495-6","article-title":"Attenuated K+ channel gene transcription in primary pulmonary hypertension","volume":"351","author":"Yuan","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib38","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1152\/jappl.2001.90.6.2249","article-title":"Alterations in a redox oxygen sensing mechanism in chronic hypoxia","volume":"90","author":"Reeve","year":"2001","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib39","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1002\/art.27607","article-title":"Association of a KCNA5 gene polymorphism with systemic sclerosis-associated pulmonary arterial hypertension in the European Caucasian population","volume":"62","author":"Wipff","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib40","doi-asserted-by":"crossref","first-page":"R273","DOI":"10.1186\/ar4124","article-title":"KCNA5 gene is not confirmed as a systemic sclerosis-related pulmonary arterial hypertension genetic susceptibility factor","volume":"14","author":"Bossini-Castillo","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2016.05.015_bib41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJMoa1211097","article-title":"A novel channelopathy in pulmonary arterial hypertension","volume":"369","author":"Ma","year":"2013","journal-title":"N Engl J Med"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0049017216300671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S0049017216300671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T16:38:37Z","timestamp":1600706317000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017216300671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0049017216300671"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2016.05.015","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726628266.793568477","asserted-by":"object"}]},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in gene expression profiles in patients with pulmonary arterial hypertension associated with scleroderma treated with tadalafil","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"http:\/\/dx.doi.org\/10.1016\/j.semarthrit.2016.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}